BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action of Roche for Integra HbA1c

Product group In-vitro diagnostics
Reference 00162/05

Corrective action of Roche for Integra HbA1c (all batches). Due to a batch inhomogeneity erroneous results for HbA1c may be obtained. The manufacturer informed the customers about the problem and how to prevent it.

Advisory notice is only available in German language.

Corrective action of Roche for Integra HbA1c , Download_VeroeffentlichtAm_EN PDF, 95KB,